NAS:RPTX (Canada)  
Repare Therapeutics Inc logo

Repare Therapeutics Inc

$ 16.06 +0.2 (+1.26%) 10:08 PM EST
P/E:
At Loss
P/B:
2.20
Market Cap:
$ 673.90M
Enterprise V:
$ 309.44M
Volume:
78.94K
Avg Vol (2M):
143.28K
Volume:
78.94K
Market Cap $:
673.90M
PE Ratio:
At Loss
Avg Vol (2-Month):
143.28K
Enterprise Value $:
309.44M
PB Ratio:
2.20
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations.
Name Current Vs Industry Vs History
Cash-To-Debt 62.84
Equity-to-Asset 0.75
Debt-to-Equity 0.02
Debt-to-EBITDA -0.22
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.25
Distress
Grey
Safe
Beneish M-Score 120.75
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -53.3
3-Year EPS without NRI Growth Rate -46.2
3-Year FCF Growth Rate -40.4

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 38.21
9-Day RSI 48.88
14-Day RSI 53.58
6-1 Month Momentum % 51.34
12-1 Month Momentum % -48.11

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.31
Quick Ratio 6.31
Cash Ratio 5.99

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -38.4

Financials (Next Earnings Date:2023-03-01 Est.)

RPTX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RPTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 120.509
EPS (TTM) ($) -0.73
Beta 0
Volatility % 75.3
14-Day RSI 53.58
14-Day ATR ($) 1.228348
20-Day SMA ($) 15.971
12-1 Month Momentum % -48.11
52-Week Range ($) 8.065 - 27.4
Shares Outstanding (Mil) 41.96

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Repare Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Repare Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.